Unknown

Dataset Information

Pharmacologic Screening Identifies Metabolic Vulnerabilities of CD8+ T Cells.


ABSTRACT: Metabolic constraints in the tumor microenvironment constitute a barrier to effective antitumor immunity and similarities in the metabolic properties of T cells and cancer cells impede the specific therapeutic targeting of metabolism in either population. To identify distinct metabolic vulnerabilities of CD8+ T cells and cancer cells, we developed a high-throughput in vitro pharmacologic screening platform and used it to measure the cell type-specific sensitivities of activated CD8+ T cells and B16 melanoma cells to a wide array of metabolic perturbations during antigen-specific killing of cancer cells by CD8+ T cells. We illustrated the applicability of this screening platform by showing that CD8+ T cells were more sensitive to ferroptosi

SUBMITTER: Drijvers JM 

PROVIDER: S-EPMC7864883 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature